Skip to main content
. 2010 Jul 2;17(11):771–779. doi: 10.1038/cgt.2010.34

Figure 5.

Figure 5

Ad.IL-24-Bax suppressed liver tumor growth in tumor-bearing nude mice model. (a) The tumor-bearing BALB/c mice (n=10) were subcutaneously injected with Ad.Luc (⋄), Ad.Bax (Inline graphic), Ad.IL-24 (▴) or Ad.IL-24-Bax (▪) (2 × 108 PFU per 100 μl). The treatment was performed every 3 days for a total of three times for each mouse and killing the mice after 3 weeks. The tumor volume of mice treated with Ad.IL-24-Bax were significantly (P<0.05) lower than those of the other groups. (b) Ad.IL-24-Bax decreased tumor weight on the tumor-bearing mice. *P<0.05, vs the Ad.Luc group. #P<0.05 vs the Ad.IL-24 group.